ArticlePLoS neglected tropical diseases2017
Cryptococcal meningitis: A neglected NTD?
Abstract read
In one paragraph
Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis.Frontiers in medicine · 2022Pooled it
- Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.BMC infectious diseases · 2020Pooled it
- Hospitalization Free-Survival, Adverse Drug Reactions, and Retention in Care Outcomes of an Outpatient Treatment Model for Cryptococcal Meningitis in PLWH in Maputo, Mozambique.Tropical medicine and infectious disease · 2026Article
- Integrative Transcriptomic and Systems Biology Analyses IdentifyMicroorganisms · 2026Article
- Article
- iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis.Frontiers in microbiology · 2025Article
- Design of an epitope-based peptide vaccine against Cryptococcus neoformans.FEBS open bio · 2024Article
- A nomogram to predict cryptococcal meningitis in patients with pulmonary cryptococcosis.Heliyon · 2024Article
- Article
- Article
- The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity.British medical bulletin · 2023Article
- The WHO fungal priority pathogens list as a game-changer.Nature reviews. Microbiology · 2023Article
- Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda.PloS one · 2023Article
- Disseminated cryptococcosis by biological therapy: We must manage the riskBiomedica : revista del Instituto Nacional de Salud · 2022Article
- Challenges in Serologic Diagnostics of Neglected Human Systemic Mycoses: An Overview on Characterization of New Targets.Pathogens (Basel, Switzerland) · 2022Review
- Impact of a Cryptococcal meningitis diagnosis and treatment program at Lira Regional Referral Hospital in rural, Northern Uganda.PLOS global public health · 2022Article
- Reimagining the future of African brain health: Perspectives for basic research on the pathogenesis of cryptococcal meningitis.Brain, behavior, & immunity - health · 2021Article
- Obstructive Hydrocephalus Secondary to Cryptococcal Meningitis in an Immunocompetent Adult.Cureus · 2021Article
- Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans.Scientific reports · 2021Article
- Coccidioidomycosis in Brazil: Historical Challenges of a Neglected Disease.Journal of fungi (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Síle F MolloyCentre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.ORCID http://orcid.org/0000-0001-8847-2325
Tom ChillerMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Gregory S GreeneMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jessica BurryMedecins Sans Frontières Access Campaign, Médecins Sans Frontières, Geneva, Switzerland.
Nelesh P GovenderNational Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), Johannesburg, South Africa.
Cecilia KanyamaUniversity of North Carolina Project, Lilongwe, Malawi.
Sayoki MfinangaNational Institute of Medial Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania.
Sokoine LesikariNational Institute of Medial Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania.
Yacouba N MapoureCentral Hospital, Yaoundé, Cameroon.
Charles KouanfackDepartment of Internal Medicine, Douala General Hospital, Douala, Cameroon.
Victor SiniDepartment of Internal Medicine, Douala General Hospital, Douala, Cameroon.
Elvis TemfackCentral Hospital, Yaoundé, Cameroon.
David R BoulwareDivision of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America.
Francoise DromerInstitut Pasteur, Molecular Mycology-CNRS URA3012, Department of Mycology, Paris, France.
David W DenningGlobal Action Fund for Fungal Infections (GAFFI), Geneva, Switzerland.
Jeremy DayOxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam.
Neil R H StoneCentre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
Tihana BicanicCentre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
Joseph N JarvisDepartment of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Olivier LortholaryInstitut Pasteur, Molecular Mycology-CNRS URA3012, Department of Mycology, Paris, France.
Thomas S HarrisonCentre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
Shabbar JaffarDepartment of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Angela LoyseCentre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.
Funding
Malawi HIV Implementation Research Scientist Training Program (MHIRST)D43TW010060 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MINA CHRISTINE HOSSEINIPOUR, Victor Mwapasa · 2015 to 2026
$3.8MFIC NIH HHS D43 TW010060
Abstract
PubMed holds no abstract for this paper.
Indexed as
Neglected DiseasesTropical MedicineAntifungal AgentsBiomedical ResearchGlobal HealthHumansMeningitis, CryptococcalAntifungal Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC0
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.